Puradelta Lestari Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Puradelta Lestari Tbk. trades at Rp148 (market cap 7.09T, 34.15M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Puradelta Lestari Tbk. is far larger — about 15.1× Prodia Diagnostic Line Tbk's market cap, and Puradelta Lestari Tbk. is more actively traded (34.15M versus 28.43M). Which is the better fit depends on your goals.
| DMAS | PRDL | |
|---|---|---|
Market Cap | 7.09T | 470.58B |
Volume | 34.15M | 28.43M |
Lot | 341.53K | 284.34K |
Turnover | 5.03B | 7.8B |
Average Price | 147.27 | 274.19 |
Value | 5.03B | 7.8B |
Indicative Equilibrium Price | 148 | 270 |
Indicative Equilibrium Volume | 20.98K | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.
Read more on DMAS →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →